rs79761183

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_018100.4(EFHC1):​c.662G>A​(p.Arg221His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00132 in 1,614,130 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R221C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0071 ( 21 hom., cov: 32)
Exomes 𝑓: 0.00072 ( 11 hom. )

Consequence

EFHC1
NM_018100.4 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 1.94

Publications

16 publications found
Variant links:
Genes affected
EFHC1 (HGNC:16406): (EF-hand domain containing 1) This gene encodes an EF-hand-containing calcium binding protein. The encoded protein likely plays a role in calcium homeostasis. Mutations in this gene have been associated with susceptibility to juvenile myoclonic epilepsy and juvenile absence epilepsy. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
EFHC1 Gene-Disease associations (from GenCC):
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005691111).
BP6
Variant 6-52452776-G-A is Benign according to our data. Variant chr6-52452776-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 205384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0071 (1081/152274) while in subpopulation AFR AF = 0.0245 (1017/41534). AF 95% confidence interval is 0.0232. There are 21 homozygotes in GnomAd4. There are 510 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1081 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFHC1NM_018100.4 linkc.662G>A p.Arg221His missense_variant Exon 4 of 11 ENST00000371068.11 NP_060570.2 Q5JVL4-1B2CKC5
EFHC1NM_001172420.2 linkc.605G>A p.Arg202His missense_variant Exon 5 of 12 NP_001165891.1 Q5JVL4-3B2CKC5
EFHC1NR_033327.2 linkn.731G>A non_coding_transcript_exon_variant Exon 4 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFHC1ENST00000371068.11 linkc.662G>A p.Arg221His missense_variant Exon 4 of 11 1 NM_018100.4 ENSP00000360107.4 Q5JVL4-1

Frequencies

GnomAD3 genomes
AF:
0.00711
AC:
1082
AN:
152156
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0246
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00197
AC:
495
AN:
251412
AF XY:
0.00161
show subpopulations
Gnomad AFR exome
AF:
0.0254
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000716
AC:
1046
AN:
1461856
Hom.:
11
Cov.:
32
AF XY:
0.000656
AC XY:
477
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.0239
AC:
800
AN:
33480
American (AMR)
AF:
0.00199
AC:
89
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39690
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000576
AC:
64
AN:
1111992
Other (OTH)
AF:
0.00142
AC:
86
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
68
136
205
273
341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00710
AC:
1081
AN:
152274
Hom.:
21
Cov.:
32
AF XY:
0.00685
AC XY:
510
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0245
AC:
1017
AN:
41534
American (AMR)
AF:
0.00333
AC:
51
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68030
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
51
102
152
203
254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00233
Hom.:
6
Bravo
AF:
0.00854
ESP6500AA
AF:
0.0238
AC:
105
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00234
AC:
284
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
Sep 30, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 03, 2015
GeneDx
Significance:not provided
Review Status:no classification provided
Collection Method:clinical testing

p.Arg221His (CGT>CAT): c.662 G>A in exon 4 of the EFHC1 gene (NM_018100.3). P77T and R221H were identified on the same chromosome and co-segregated with juvenile myoclonic epilepsy (JME) in two families (Suzuki et al., 2004). Functional studies suggest that both P77T and R221H impair apoptosis and alter calcium currents (Suzuki et al., 2004). However, both P77T and R221H have subsequently been identified in 1-3% of the African population in the NHLBI ESP Exome Variant Project and the 1000 Genomes Database. P77T results in a nonconservative amino acid substitution, while the R221H substitution is a conservative change. Both of these missense substitutions alter positions in the protein that are not highly conserved throughout evolution or in related proteins, and multiple in silico models predict they are likely benign. Therefore, currently available evidence suggests that P77T and R221H may be associated with JME, although the possibility that they are benign variants cannot be completely excluded. The variant is found in CHILD-EPI,EPILEPSY,INFANT-EPI panel(s). -

Dec 02, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Apr 08, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 23, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

EFHC1-related disorder Benign:1
Jun 30, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.032
T;.;.;T;T;T;T;T;T;.;T;.;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.60
D
LIST_S2
Uncertain
0.92
D;D;.;D;D;D;D;D;D;D;D;.;D
MetaRNN
Benign
0.0057
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.4
.;.;.;L;.;.;.;.;.;.;.;.;.
PhyloP100
1.9
PrimateAI
Benign
0.26
T
PROVEAN
Uncertain
-2.5
.;.;.;N;.;.;.;.;.;.;.;.;N
REVEL
Benign
0.087
Sift
Benign
0.036
.;.;.;D;.;.;.;.;.;.;.;.;D
Sift4G
Uncertain
0.043
.;.;.;D;.;.;.;.;.;.;.;.;T
Polyphen
0.043
.;.;.;B;.;.;.;.;.;.;.;.;.
Vest4
0.22, 0.24
MVP
0.77
MPC
0.11
ClinPred
0.011
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.059
gMVP
0.48
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79761183; hg19: chr6-52317574; API